NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/05/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization409.35 mln
Float17.83 mln
Earnings Date05/18/2026
Piotroski F-Score
3
/ 9
Below average
Relative Strength
14
/ 100
Significantly lagging
Debt / Equity
0.00
Debt-free
ROE
-41.96
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Benitec Biopharma is a clinical-stage company working to create new treatments based on genetic medicine. Using its proprietary platform, the company develops therapies that can switch off harmful genes while simultaneously introducing healthy replacement genes ? all through a single treatment. Its lead program targets oculopharyngeal muscular dystrophy, a condition that causes progressive difficulty swallowing. The company operates from its headquarters in Hayward, California.
